Cargando…

The suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study

Here, we found that down-regulated expression of BTG3 might be positively correlated with colorectal carcinogenesis and its overexpression suppressed proliferation, glycolysis, mitochondrial respiration, cell cycle progression, migration, and invasion, and induced apoptosis, senescence and different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hua-Chuan, He, Hao-Yu, Wu, Ji-Cheng, Li, Jing, Zhao, Shuang, Zhao, Gui-Feng, Jiang, Hua-Mao, Yu, Xue-Wen, Li, Zhi-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392331/ https://www.ncbi.nlm.nih.gov/pubmed/28407690 http://dx.doi.org/10.18632/oncotarget.15438

Ejemplares similares

BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial–Mesenchymal Transition
por: Zhao, Shuang, et al.
Publicado: (2020)

BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy
por: Zheng, Hua-chuan, et al.
Publicado: (2015)

The in vitro and in vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target
por: Zheng, Hua-chuan, et al.
Publicado: (2017)

The Suppressing Effects of Dkk3 Expression on Aggressiveness and Tumorigenesis of Colorectal Cancer
por: Zhao, Shuang, et al.
Publicado: (2020)

SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study
por: Yang, Xue-feng, et al.
Publicado: (2016)

BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers
por: Zhao, Shuang, et al.
Publicado: (2016)

Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma
por: Deng, Boya, et al.
Publicado: (2013)

The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells
por: Lu, Hang, et al.
Publicado: (2016)

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas
por: Zhao, Yang, et al.
Publicado: (2013)

The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy
por: Gou, Wen-feng, et al.
Publicado: (2015)

Emerging role of antiproliferative protein BTG1 and BTG2
por: Kim, Sang Hyeon, et al.
Publicado: (2022)

The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis
por: Zheng, Hua-Chuan, et al.
Publicado: (2022)

Tumor suppressors BTG1 and BTG2: Beyond growth control
por: Yuniati, Laurensia, et al.
Publicado: (2018)

The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma
por: Lv, Zhenbing, et al.
Publicado: (2013)

Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton
por: Tijchon, Esther, et al.
Publicado: (2015)

The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy
por: Zheng, Hua-chuan, et al.
Publicado: (2020)

Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo
por: Zhou, P-H, et al.
Publicado: (2015)

Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity
por: Yang, Xiuna, et al.
Publicado: (2008)

The function of BTG3 in colorectal cancer cells and its possible signaling pathway
por: Lv, Chi, et al.
Publicado: (2017)

The Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) on the Aggressive Phenotypes of Ovarian Carcinoma Cells
por: Chen, Shuo, et al.
Publicado: (2013)

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
por: Qi, Fuming, et al.
Publicado: (2022)

BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1
por: LIU, CHUNHUI, et al.
Publicado: (2015)

TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2
por: Shuai, You, et al.
Publicado: (2020)

The meta and bioinformatics analysis of fascin expression in gastric cancer: a potential marker for aggressiveness and worse prognosis
por: Zheng, Hua-Chuan, et al.
Publicado: (2017)

Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo
por: Zheng, Jianbao, et al.
Publicado: (2017)

Long non-coding RNA NBR2 suppresses the progress of colorectal cancer in vitro and in vivo by regulating the polarization of TAM
por: Lai, Fuji, et al.
Publicado: (2021)

Suppressive Effect of Huzhentongfeng on Experimental Gouty Arthritis: An In Vivo and In Vitro Study
por: Wu, Zi-cong, et al.
Publicado: (2019)

BTG Interacts with Retinoblastoma to Control Cell Fate in Dictyostelium
por: Conte, Daniele, et al.
Publicado: (2010)

Impact of AKT1 Polymorphism on DNA Damage, BTG2 Expression, and Risk of Colorectal Cancer Development
por: Zubair, Hina, et al.
Publicado: (2022)

Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo
por: Han, Jing, et al.
Publicado: (2018)

Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer
por: Chen, Di, et al.
Publicado: (2018)

Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression
por: Liu, Yang, et al.
Publicado: (2021)

Pitavastatin suppressed liver cancer cells in vitro and in vivo
por: You, He-Yi, et al.
Publicado: (2016)

The miR-146b-5p promotes Ewing’s sarcoma cells progression via suppressing the expression of BTG2
por: Qu, Lizhen, et al.
Publicado: (2021)

Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma
por: Xue, Kai, et al.
Publicado: (2021)

Beclin 1 Expression is Closely Linked to Colorectal Carcinogenesis and Distant Metastasis of Colorectal Carcinoma
por: Zhang, Mei-Ying, et al.
Publicado: (2014)

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
por: Tong, Zhongyi, et al.
Publicado: (2015)

Author Correction: Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer
por: Chen, Di, et al.
Publicado: (2019)

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
por: Chen, Hua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3pcq6vujl2v89pirec1s90cn1s